Halozyme Therapeutics, Inc.

Geneos Wealth Management Inc. HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/28/2026

Shares

12,499

Value ($000)

841

Weight

0.0%

2016 Q1 - 2025 Q4 (40 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/28/2026	841	0.0%	12,499	12/31/2025
2025 Q3	10/22/2025	902	0.0%	12,299	9/30/2025
2025 Q2	8/18/2025	540	0.0%	10,372	6/30/2025
2025 Q1	5/8/2025	597	0.0%	9,299	3/31/2025
2024 Q4	1/21/2025	189	0.0%	3,950	12/31/2024
2024 Q3	11/14/2024	232	0.0%	4,050	9/30/2024
2024 Q2	7/23/2024	238	0.0%	4,550	6/30/2024
2024 Q1	5/3/2024	177	0.0%	4,350	3/31/2024
2023 Q4	1/26/2024	161	0.0%	4,350	12/31/2023
2023 Q3	10/11/2023	166	0.0%	4,350	9/30/2023
2023 Q2	8/8/2023	157	0.0%	4,350	6/30/2023
2023 Q1	4/25/2023	166	0.0%	4,350	3/31/2023
2022 Q4	1/31/2023	259	0.0%	4,550	12/31/2022
2022 Q3	11/14/2022	156	0.0%	3,950	9/30/2022
2022 Q2	7/22/2022	618	0.0%	13,900	6/30/2022
2022 Q1	5/16/2022	570	0.0%	14,300	3/31/2022
2021 Q4	2/9/2022	583	0.0%	14,500	12/31/2021
2021 Q3	11/9/2021	607	0.0%	14,900	9/30/2021
2021 Q2	7/8/2021	703	0.0%	15,150	6/30/2021
2021 Q1	6/17/2021	809	0.0%	16,210	3/31/2021
2020 Q4	5/19/2021	670	0.0%	16,200	12/31/2020
2020 Q3	9/7/2021	540	0.0%	20,750	9/30/2020
2020 Q2	9/7/2021	569	0.0%	23,000	6/30/2020
2020 Q1	9/7/2021	411	0.0%	23,500	3/31/2020
2019 Q4	9/7/2021	438	0.0%	24,400	12/31/2019
2019 Q3	9/7/2021	392	0.0%	25,800	9/30/2019
2019 Q2	9/7/2021	451	0.0%	26,300	6/30/2019
2019 Q1	9/7/2021	433	0.0%	26,900	3/31/2019
2018 Q4	9/7/2021	398	0.0%	27,900	12/31/2018
2018 Q3	9/7/2021	506	0.0%	27,900	9/30/2018
2018 Q2	9/7/2021	470	0.0%	27,900	6/30/2018
2018 Q1	9/7/2021	552	0.0%	28,200	3/31/2018
2017 Q4	9/7/2021	577	0.1%	28,500	12/31/2017
2017 Q3	9/7/2021	500	0.0%	28,800	9/30/2017
2017 Q2	9/7/2021	369	0.0%	28,800	6/30/2017
2017 Q1	9/7/2021	392	0.0%	30,300	3/31/2017
2016 Q4	9/7/2021	291	0.0%	29,500	12/31/2016
2016 Q3	9/7/2021	334	0.0%	27,700	9/30/2016
2016 Q2	9/7/2021	251	0.0%	27,500	6/30/2016
2016 Q1	9/7/2021	261	0.0%	26,800	3/31/2016